JP Patent

JP4938259B2 — ２−オキソ−１−ピロリジン誘導体、それらの製造方法及びそれらの使用

Assigned to ユセベ ファルマ ソシエテ アノニム · Expires 2012-05-23 · 14y expired

What this patent protects

Patent listed against Briviact.

Drugs covered by this patent

Patent Metadata

Patent number
JP4938259B2
Jurisdiction
JP
Classification
—
Expires
2012-05-23
Drug substance claim
No
Drug product claim
No
Assignee
ユセベ ファルマ ソシエテ アノニム
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.